Browse by Journal or other publication
2021
Guttierez-Quintana, Rodrigo and Walker, David J. and Jackson, Mark R. and Gomez-Roman, Natividad and Chahal, Sandeep and Durant, Stephen T. and Chalmers, Anthony J. (2021) Abstract PO-017 : radiotherapy in combination with the brain penetrant ATM inhibitor AZD1390 does not exacerbate radiation toxicity of neural stem cells in vitro or in vivo. Clinical Cancer Research, 27 (8_Supp). PO-017. ISSN 1078-0432
2020
McLeod, Robert and Kumar, Rajiv and Papadatos-Pastos, Dionysis and Mateo, Joaquin and Brown, Jessica S. and Ingles Garces, Alvaro H. and Ruddle, Ruth and Decordova, Shaun and Jueliger, Simone and Ferraldeschi, Roberta and Maiques, Oscar and Sanz-Moreno, Victoria and Jones, Paul and Traub, Stephanie and Halbert, Gavin and Mellor, Sarah and Swales, Karen E. and Raynaud, Florence I. and Garrett, Michelle D. and Banerji, Udai (2020) First-in-human study of AT13148, a dual ROCK-AKT inhibitor in patients with solid tumors. Clinical Cancer Research, 26. pp. 4777-4784. ISSN 1078-0432
2019
Jackson, Mark and Gomez-Roman, Natividad and Chalmers, Anthony (2019) Inhibitors of poly(ADP-ribose) glycohydrolase (PARG) exhibit single agent therapeutic activity and sensitize glioblastoma cells to ionizing radiation. Clinical Cancer Research, 21 (supp 4). iv12. ISSN 1078-0432
2008
Foster, Paul A. and Chander, S.K. and Newman, Simon P. and Woo, L.W. Lawrence and Sutcliffe, O.B. and Bubert, C. and Zhou, Dujin and Chen, Shiuan and Potter, B.V.L. and Reed, M.J. and Purohit, A. (2008) A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor. Clinical Cancer Research, 14. pp. 6469-6477. ISSN 1557-3265
2006
Ranson, Malcolm and Middleton, Mark, R. and Bridgewater, John and Lee, Siow Ming and Dawson, M. and Jowle, Debra and Halbert, G.W. and Waller, Sue and McGrath, Helen and Gumbrell, Lindsey and McElhinney, R. Stanley and Donnelly, Dorothy and McMurry, T. Brian H. and Margison, Geoffrey, P. (2006) Lomeguatrib, a potent inhibitor of o-6-alkylguanine-DNA-alkyltrasnferase: phase i safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumours. Clinical Cancer Research, 12 (5). pp. 1577-1584. ISSN 1557-3265
Stanway, Susannah J and Purohit, Atul and Woo, L W Lawrence and Sufi, Saulat and Vigushin, David and Ward, Rebecca and Wilson, Richard H and Stanczyk, Frank Z and Dobbs, Nicola and Kulinskaya, Elena and Elliott, Moira and Potter, Barry V L and Reed, Michael J and Coombes, R Charles (2006) Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor. Clinical Cancer Research, 12 (5). pp. 1585-92. ISSN 1078-0432
2004
Decensi, A. and Bonanni, B. and Baglietto, L. and Guerrieri-Gonzaga, A. and Ramazzotto, F. and Johansson, H. and Robertson, C. and Marinucci, I. (2004) A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers. Clinical Cancer Research, 10 (13). pp. 4389-4397. ISSN 1557-3265
Kisanga, E.R. and Gjerde, J. and Guerrieri-Gonzaga, A. and Pigatto, F. and Pesci-Feltri, A. and Robertson, C. and Serrano, D. and Pelosi, G. (2004) Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial. Clinical Cancer Research, 10 (7). pp. 2336-2343. ISSN 1557-3265
2003
Seddon, B.M. and Payne, G.S. and Simmons, L. and Ruddle, R. and Grimshaw, R. and Tan, S. and Turner, A. and Raynaud, F. and Halbert, G.W. and Leach, M.O. and Judson, I. and Workman, P. (2003) A phase I study of SR-4554 via intravenous administration for noninvasive investigation of tumor hypoxia by magnetic resonance spectroscopy in patients with malignancy. Clinical Cancer Research, 9 (14). pp. 5101-12. ISSN 1557-3265